Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2025)
Historic Interest & Investment Income for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $10.9 million.
- Beam Therapeutics' Interest & Investment Income fell 1009.32% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year decrease of 1236.11%. This contributed to the annual value of $49.1 million for FY2024, which is 518.04% up from last year.
- Latest data reveals that Beam Therapeutics reported Interest & Investment Income of $10.9 million as of Q3 2025, which was down 1009.32% from $12.3 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Interest & Investment Income ranged from a high of $14.2 million in Q2 2024 and a low of -$52000.0 during Q2 2021
- For the 5-year period, Beam Therapeutics' Interest & Investment Income averaged around $7.6 million, with its median value being $10.0 million (2023).
- Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 12080.0% in 2021, then surged by 5525555.56% in 2022.
- Quarter analysis of 5 years shows Beam Therapeutics' Interest & Investment Income stood at $54000.0 in 2021, then skyrocketed by 13994.44% to $7.6 million in 2022, then soared by 58.51% to $12.1 million in 2023, then decreased by 9.42% to $10.9 million in 2024, then decreased by 0.23% to $10.9 million in 2025.
- Its Interest & Investment Income stands at $10.9 million for Q3 2025, versus $12.3 million for Q2 2025 and $9.9 million for Q1 2025.